Frauenheilkunde up2date, Table of Contents Frauenheilkunde up2date 2013; 7(4): 247-262DOI: 10.1055/s-0032-1325082 Allgemeine Gynäkologie und gynäkologische Onkologie Georg Thieme Verlag KG Stuttgart · New York B3-Läsionen der Mamma – Besonderheiten in Diagnostik und Therapie Sarah Föger , Ines Gruber , Katja C. Siegmann-Luz , Annette Staebler , Markus Hahn Recommend Article Abstract Buy Article All articles of this category Full Text References Literatur 1 NHSBSP. Guidelines for Non-Operative Diagnostic Procedures and Reporting in Breast Cancer Screening (NHSBSP Publication No. 50). Non-operative Diagnosis Subgroup of the National Coordinating Group for Breast Screening Pathology (NHSBSP). NHS Cancer Screening Programmes 2001; Publication No. 50 2 Amendoeira I. Quality assurance guidelines for pathology: cytological and histological nonoperative procedures. In: European guidelines for quality assurance in breast cancer screening and diagnosis. Office for Official Publications of the European Communities; 2006. a 221-256 3 Deutsche Krebsgesellschaft e.V. (DKG), Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. AWMF-Registernummer: 032-045. 4 Lakhani SR, Ellis IO, Schnitt SJ et al, eds. WHO Classification of Tumours of the Breast. Lyon: IARC; 2012 5 Becker AK, Gordon PB, Harrison DA et al. Flat ductal intraepithelial neoplasia 1A diagnosed at stereotactic core needle biopsy: Is excisional biopsy indicated?. Am J Roentgenol 2013; 200: 682-688 6 Heywang-Köbrunner SH, Nährig J, Hacker A et al. B3 Lesions: radiological assessment and multi-disciplinary aspects. Breast Care 2010; 5: 209-217 7 Moinfar F. Flat ductal intraepithelial neoplasia of the breast. A review of diagnostic criteria, differential diagnoses, molecular-genetic findings, and clinical relevance – it is time to appreciate the Azzopardi Concept!. Arch Pathol Lab Med 2009; 133: 879-892 8 AGO e.V. in der DGGG e.V. sowie der DKG e.V.. Guidelines Breast Version 2013.1D. http://www.ago-online.de 9 Cuneo KC, Dash RC, Wilke LG et al. Risk of invasive breast cancer and ductal carcinoma in situ in women with atypical papillary lesions of the breast. Breast 2012; 18: 475-478 10 Swapp RE, Glazebrook KN, Jones KN et al. Management of benign intraductal solitary papilloma diagnosed on core needle biopsy. Ann Surg Oncol 2013; Jan 13. [Epub ahead of print] 11 Tseng HS, Chen YL, Chen ST et al. The management of papillary lesion of the breast by core needle biopsy. Eur J Surg Oncol 2009; 35: 21-24 12 Hussain M, Cunnick GH. Management of lobular carcinoma in situ and atypical lobular hyperplasia of the breast – a review. Eur J Surg Oncol 2011; 37: 279-289 13 Rakha EA, Lee AH, Jenkins JA et al. Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Int J Cancer 2011; 129: 1417-1424 14 Guillot E, Couturaud B, Reyal F et al. Breast Cancer Study Group of the Institut Curie. Management of phyllodes breast tumors. Breast J 2011; 17: 129-137 15 Cuzick J, Forbes J, Edwards R et al. IBIS investigators. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 2002; 360: 817-824
